Skip to content
akaturk Academic measurement
2025 SJR Q2 JCR Q2 · 3,1 OA 11 matched articles SCIE

Journal detail

Rheumatology and Therapy

Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 21986576
  • 21986584
Scopus 0,991 SJR
Scopus Q2 SJR Q
WoS Q2 JCR Q
WoS 3,1 JIF
Scopus 47 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,991
  • Quartile Q2
  • H-Index 47
  • Cites/doc 2,97
  • Docs (3y) 319
  • Cites (3y) 932

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q2
  • JIF 3,1
  • 5Y JIF 3,6
  • JCI 0,9

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Immunology and Allergy Q2
  • Rheumatology Q2

Areas

  • Medicine

WoS categories

  • Rheumatology

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q2 0,991 3,1 3,6 0,9 Q2 47
2024 Q2 Q2 1,099 2,9 3,5 0,82 Q2 40
2023 Q2 Q2 1,071 2,9 3,6 0,84 Q2 40
2022 Q1 Q3 1,242 3,8 3,8 0,78 Q2 40
2021 Q2 Q3 1,076 4,1 4,7 0,83 Q2 40
2020 — Q3 — 3,5 4,6 0,83 Q2 40
2019 — Q2 — 3,6 — 0,85 Q2 40
2017 — — — — — — — 40
2016 — — — — — — — 40
2015 — — — — — — — 40
2014 — — — — — — — 40

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 RHEUMATOLOGY SCIE Q2 Q2 22/58
2024 RHEUMATOLOGY SCIE Q2 Q2 20/58
2023 RHEUMATOLOGY SCIE Q2 Q2 20/57
2022 RHEUMATOLOGY SCIE Q3 Q2 19/34
2021 RHEUMATOLOGY SCIE Q3 Q2 18/34
2020 RHEUMATOLOGY SCIE Q3 Q2 21/34
2019 RHEUMATOLOGY SCIE Q2 Q2 13/32